Is it time for a new standard for the culture of iPSCs?
For those delivering advanced therapy medicinal products, the question of assessing and managing cell population heterogeneity presents an ongoing challenge. Solentim and EverCell Bio addressed this topic at a recent
Solentim to present online at the 9th Cell Line Development & Engineering Asia digital conference
Solentim is happy to announce that it will be presenting at the 9th Cell Line Development & Engineering Asia conference, taking place 3-5 November 2020. This digitally delivered event brings together the
Solentim Cell Metric and VIPS selected by US Government Lab to support latest vaccine research
As part of the concerted fight against COVID-19, the Vaccine Research Center (VRC) at the National Institute for Allergy and Infectious Diseases at the U.S. National Institutes of Healthhas invested
Solentim to supply cell line development solutions for Samsung Biologics’ new R&D center in San Francisco
Bournemouth, UK, 7th October 2020 / Solentim is pleased to announce the adoption of its VIPS™ single cell seeding platform and Cell Metric® CLD into Samsung Biologics’ new research and development facility in San Francisco, CA. These
Field Applications Scientist/Applications Specialist US – West Coast (ideally Bay Area)
Home-Based with Extensive Travel $Competitive Solentim is an award-winning Life Sciences company committed to transforming the discovery and development of new biologics, to get materials into the clinic faster and
Solentim launches new workflow for single cell cloning of stem cells
VIPS™ + MatriClone™ combination ensures high efficiency seeding of hiPSCs with high viability Solentim, the global leader for solutions to create, isolate and characterize the highest value cells for the development of new biological